Biodexa Pharmaceticals Stock Forecast - Simple Moving Average
| BDRX Stock | 2.20 0.05 2.33% |
Biodexa Stock outlook is based on your current time horizon.
At this time, the RSI of Biodexa Pharmaceticals' share price is approaching 41 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Biodexa Pharmaceticals, making its price go up or down. Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (0.40) | EPS Estimate Next Year (0.10) | Wall Street Target Price 178.3005 | Quarterly Revenue Growth (0.64) |
Using Biodexa Pharmaceticals hype-based prediction, you can estimate the value of Biodexa Pharmaceticals from the perspective of Biodexa Pharmaceticals response to recently generated media hype and the effects of current headlines on its competitors.
Biodexa Relative Strength Index
The Simple Moving Average forecasted value of Biodexa Pharmaceticals on the next trading day is expected to be 2.20 with a mean absolute deviation of 0.45 and the sum of the absolute errors of 26.45.Biodexa Pharmaceticals Hype to Price Pattern
Investor biases related to Biodexa Pharmaceticals' public news can be used to forecast risks associated with an investment in Biodexa. The trend in average sentiment can be used to explain how an investor holding Biodexa can time the market purely based on public headlines and social activities around Biodexa Pharmaceticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biodexa Pharmaceticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biodexa Pharmaceticals.
The Simple Moving Average forecasted value of Biodexa Pharmaceticals on the next trading day is expected to be 2.20 with a mean absolute deviation of 0.45 and the sum of the absolute errors of 26.45. Biodexa Pharmaceticals after-hype prediction price | USD 2.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Biodexa Pharmaceticals to cross-verify your projections. Biodexa Pharmaceticals Additional Predictive Modules
Most predictive techniques to examine Biodexa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biodexa using various technical indicators. When you analyze Biodexa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Biodexa Pharmaceticals Simple Moving Average Price Forecast For the 27th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Biodexa Pharmaceticals on the next trading day is expected to be 2.20 with a mean absolute deviation of 0.45, mean absolute percentage error of 0.67, and the sum of the absolute errors of 26.45.Please note that although there have been many attempts to predict Biodexa Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biodexa Pharmaceticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Biodexa Pharmaceticals Stock Forecast Pattern
| Backtest Biodexa Pharmaceticals | Biodexa Pharmaceticals Price Prediction | Buy or Sell Advice |
Biodexa Pharmaceticals Forecasted Value
In the context of forecasting Biodexa Pharmaceticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Biodexa Pharmaceticals' downside and upside margins for the forecasting period are 0.02 and 19.38, respectively. We have considered Biodexa Pharmaceticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Biodexa Pharmaceticals stock data series using in forecasting. Note that when a statistical model is used to represent Biodexa Pharmaceticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.0412 |
| Bias | Arithmetic mean of the errors | 0.098 |
| MAD | Mean absolute deviation | 0.4483 |
| MAPE | Mean absolute percentage error | 0.1003 |
| SAE | Sum of the absolute errors | 26.45 |
Predictive Modules for Biodexa Pharmaceticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biodexa Pharmaceticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biodexa Pharmaceticals After-Hype Price Density Analysis
As far as predicting the price of Biodexa Pharmaceticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biodexa Pharmaceticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biodexa Pharmaceticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biodexa Pharmaceticals Estimiated After-Hype Price Volatility
In the context of predicting Biodexa Pharmaceticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biodexa Pharmaceticals' historical news coverage. Biodexa Pharmaceticals' after-hype downside and upside margins for the prediction period are 0.11 and 19.22, respectively. We have considered Biodexa Pharmaceticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biodexa Pharmaceticals is abnormally volatile at this time. Analysis and calculation of next after-hype price of Biodexa Pharmaceticals is based on 3 months time horizon.
Biodexa Pharmaceticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Biodexa Pharmaceticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biodexa Pharmaceticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biodexa Pharmaceticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.52 | 17.18 | 0.81 | 0.19 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.20 | 2.15 | 0.00 |
|
Biodexa Pharmaceticals Hype Timeline
Biodexa Pharmaceticals is currently traded for 2.20. The entity has historical hype elasticity of 0.81, and average elasticity to hype of competition of -0.19. Biodexa is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.52%. %. The volatility of related hype on Biodexa Pharmaceticals is about 4655.83%, with the expected price after the next announcement by competition of 2.01. The company has price-to-book (P/B) ratio of 0.12. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biodexa Pharmaceticals recorded a loss per share of 27.0. The entity last dividend was issued on the 3rd of March 2020. The firm had 1:10 split on the 31st of July 2025. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Historical Fundamental Analysis of Biodexa Pharmaceticals to cross-verify your projections.Biodexa Pharmaceticals Related Hype Analysis
Having access to credible news sources related to Biodexa Pharmaceticals' direct competition is more important than ever and may enhance your ability to predict Biodexa Pharmaceticals' future price movements. Getting to know how Biodexa Pharmaceticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biodexa Pharmaceticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INM | InMed Pharmaceuticals | 0.02 | 8 per month | 0.00 | (0.16) | 7.48 | (9.30) | 30.84 | |
| GNPX | Genprex | (0.13) | 7 per month | 0.00 | (0.23) | 18.18 | (16.42) | 44.30 | |
| GRI | GRI Bio | (0.48) | 5 per month | 0.00 | (0.25) | 11.88 | (14.49) | 77.17 | |
| JAGX | Jaguar Animal Health | (0.12) | 7 per month | 0.00 | (0.06) | 9.71 | (16.87) | 125.57 | |
| ESLA | Estrella Immunopharma | 0.04 | 8 per month | 0.00 | (0.07) | 12.23 | (15.49) | 50.95 | |
| GLMD | Galmed Pharmaceuticals | 0.11 | 7 per month | 0.00 | (0.15) | 8.04 | (9.20) | 21.39 | |
| CNSP | CNS Pharmaceuticals | 0.01 | 8 per month | 0.00 | (0.12) | 7.22 | (7.57) | 26.44 | |
| BIVI | Biovie Inc | (0.39) | 19 per month | 0.00 | (0.18) | 6.62 | (7.30) | 19.38 | |
| KZIA | Kazia Therapeutics Ltd | (2.70) | 7 per month | 9.73 | 0.05 | 14.69 | (18.36) | 78.79 | |
| CANF | Can Fite Biopharma | (0.05) | 8 per month | 0.00 | (0.15) | 10.40 | (8.59) | 38.42 |
Other Forecasting Options for Biodexa Pharmaceticals
For every potential investor in Biodexa, whether a beginner or expert, Biodexa Pharmaceticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biodexa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biodexa. Basic forecasting techniques help filter out the noise by identifying Biodexa Pharmaceticals' price trends.Biodexa Pharmaceticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biodexa Pharmaceticals stock to make a market-neutral strategy. Peer analysis of Biodexa Pharmaceticals could also be used in its relative valuation, which is a method of valuing Biodexa Pharmaceticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biodexa Pharmaceticals Market Strength Events
Market strength indicators help investors to evaluate how Biodexa Pharmaceticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biodexa Pharmaceticals shares will generate the highest return on investment. By undertsting and applying Biodexa Pharmaceticals stock market strength indicators, traders can identify Biodexa Pharmaceticals entry and exit signals to maximize returns.
Biodexa Pharmaceticals Risk Indicators
The analysis of Biodexa Pharmaceticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biodexa Pharmaceticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biodexa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.85 | |||
| Standard Deviation | 16.61 | |||
| Variance | 275.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biodexa Pharmaceticals
The number of cover stories for Biodexa Pharmaceticals depends on current market conditions and Biodexa Pharmaceticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biodexa Pharmaceticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biodexa Pharmaceticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Biodexa Pharmaceticals Short Properties
Biodexa Pharmaceticals' future price predictability will typically decrease when Biodexa Pharmaceticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biodexa Pharmaceticals often depends not only on the future outlook of the potential Biodexa Pharmaceticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biodexa Pharmaceticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 619.5 K | |
| Cash And Short Term Investments | 1.7 M |
Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.